IMVT: Immunovant Inc Sotuvga nisbatan narx
Immunovant, Inc. (IMVT) AQSHda kam uchraydigan patologiyalar uchun maxsus davolash vositalarini ishlab chiqish orqali biznes barqarorligini saqlab qolmoqda. Ushbu tarixiy P/S grafigi bozor ishonchining ko'rsatkichi bo'lib xizmat qiladi va bunda bazaviy qiymat sifatida qayd etilgan. Immunovant, Inc. (IMVT) immun tizimi buzilishlarini davolash uchun ilg'or antitanalarni ishlab chiqmoqda va mahsulotlarini xalqaro miqyosda ishga tushirishdan oldin molekulalarning yakuniy sinovlarini zudlik bilan yakunlashni maqsad qilgan.
Immunovant Corp (IMVT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Immunovant, Inc.|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Immunovant Therapeutics|IMVT - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Immunovant Corp|IMVT - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Immunovant|Tezkor likvidlik immunovant.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
IMVT - Sof foyda|Prognoz qilingan kelajakdagi foyda Immunovant, Inc.|IMVT - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Immunovant Inc|IMVT - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Immunovant Corp|IMVT - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Immunovant|IMVT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi immunovant.com|IMVT - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Immunovant, Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:immunovant.com (IMVT)
P/S koeffitsiyenti daromadning bir rubli bozor qiymatini o'lchaydi, bu esa aktivlarni monetizatsiya qilish samaradorligini va sotuvlar to'xtab qolgan davrda biznes uchun haddan tashqari ko'p to'lov qilish xavfini baholash imkonini beradi. Immunovant, Inc. (IMVT) kompaniyasi uchun, uning qiymati joriy tijorat mahsulotlarisiz monoklonal antitelalarni ishlab chiqish dinamikasiga asoslangan holda, kompaniyaning joriy P/S koeffitsiyenti bozorning kelgusi sinov bosqichlariga bo'lgan kutganlarini va emitentning umumiy moliyaviy barqarorligini aks ettiradi.
Immunovant, Inc. raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|Kiniksa Pharmaceuticals (KNSA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati grifols.com|Narxning daromadga nisbati Adaptive Biotechnologies Corporation|Kapitalizatsiyaning daromadga nisbati Celldex Therapeutics Inc (CLDX)|Kapitalizatsiyaning daromadga nisbati AUPH (Aurinia Pharma)|P/S multiplikatori BioCryst Corp (BCRX)|Narxning daromadga nisbati Vera Therapeutics, Inc. VERA|DNTH: Kapitalizatsiya va daromad nisbati|PHVS - Narxning daromadga nisbati|Sotuvga nisbatan narx AbCellera Biologics Inc.|TRML (Tourmaline Corp) - Kapitalizatsiyaning daromadga nisbati|PGEN (Precigen Corp) - Narxning daromadga nisbati|PHAR (Pharming Group N.V.) - P/S multiplikatori|P/S multiplikatori nektar.com|Narxning daromadga nisbati Upstream Bio (UPB)|Zenas Bio - Kapitalizatsiya va daromad nisbati|Immunome Corp - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati GOSS (Gossamer Bio Corp.)|KALV: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SEPN (septerna.com)|PVLA: P/S multiplikatori|SVRA - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Rigel Pharmaceuticals Inc|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio Inc.)|P/S multiplikatori ATXS|Kapitalizatsiyaning daromadga nisbati engene.com ENGN|RAPT Therapeutics - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Aerovate Therapeutics, Inc. (JBIO)|Aclaris - P/S multiplikatori|Narx/daromad koeffitsiyenti Kyverna Therapeutics, Inc KYTX|Tiziana Life Sciences (TLSA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati cabalettabio.com|Kapitalizatsiyaning daromadga nisbati VTYX|Narxning daromadga nisbati THTX|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati ELDN|Narxning daromadga nisbati Agenus AGEN|CLYM (climbbio.com) - Narxning sotuvga nisbati|Zura Bio - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATYR (aTyr Pharma Inc)|ADAG: P/S multiplikatori|Ikena Oncology (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Labs Inc|EQ: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Connect Biopharma (CNTB)|Kapitalizatsiyaning daromadga nisbati immunic-therapeutics.com IMUX|P/S multiplikatori ATRA (Atara Bio)|P/S multiplikatori InflaRx NV IFRX|XFOR: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACET (Adicet Bio)|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Bio|Kapitalizatsiyaning daromadga nisbati Kezar Life Sciences Inc (KZR)|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|Kapitalizatsiyaning daromadga nisbati akaritx.com AKTX|Enlivex Therapeutics Ltd. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Q32 Bio Inc QTTB|GOVX - Narxning daromadga nisbati|EDSA (Edesa Biotech Corp) - Kapitalizatsiya va daromad nisbati|IBIO: P/S multiplikatori|Sotuvga nisbatan narx Carisma Therapeutics Inc. (CARM)|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Bolt Bio (BOLT) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Kapitalizatsiyaning daromadga nisbati aptevotherapeutics.com APVO|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI: Kapitalizatsiyaning daromadga nisbati|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati REVB|Narxning daromadga nisbati Indaptus Therapeutics|Sotuvga nisbatan narx scinai.com SCNI|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|Narxning daromadga nisbati AFMD (affimed.com)|P/S multiplikatori ALLK (Allakos)|P/S multiplikatori HOOKIPA Pharma, Inc. HOOK|IGMS - Narxning daromadga nisbati|ITOS (iteostherapeutics.com) - Kapitalizatsiya va daromad nisbati|OCEA (Ocean Biomedical) - Kapitalizatsiyaning daromadga nisbati|TCBP: Kapitalizatsiyaning sotish hajmiga nisbati|Kapitalizatsiyaning daromadga nisbati THRD
